Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.
Köbel M, Yang RZ, Kang EY, Al-Shamma Z, Cook LS, Kinloch M, Carey MS, Hopkins L, Nelson GS, McManus KJ, Vizeacoumar FS, Vizeacoumar FJ, Freywald A, Fu Y, Reuss DE, Lee CH. Köbel M, et al. Among authors: carey ms. Gynecol Oncol. 2023 Nov;178:80-88. doi: 10.1016/j.ygyno.2023.09.016. Epub 2023 Oct 9. Gynecol Oncol. 2023. PMID: 37820398
Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.
Wong NKY, Llaurado Fernandez M, Kommoss FKF, Praveen Kumar P, Kim H, Liu J, Zhang G, Coatham M, Lin YY, Haegert AM, Volik S, Le Bihan S, Collins CC, Fu Y, Postovit LM, von Deimling A, Wu R, Xue H, Wang Y, Köbel M, Carey MS, Lee CH. Wong NKY, et al. Among authors: carey ms. Gynecol Oncol. 2023 Sep;176:162-172. doi: 10.1016/j.ygyno.2023.07.016. Epub 2023 Aug 7. Gynecol Oncol. 2023. PMID: 37556934
Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes.
Dhillon G, Llaurado-Fernandez M, Tessier-Cloutier B, Sy K, Bassiouny D, Han G, Wong NKY, McRae K, Kinloch M, Pors J, Hopkins L, Covens A, Köbel M, Lee CH, Carey MS. Dhillon G, et al. Among authors: carey ms. Front Oncol. 2024 Aug 16;14:1408196. doi: 10.3389/fonc.2024.1408196. eCollection 2024. Front Oncol. 2024. PMID: 39220645 Free PMC article.
Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer.
Kumar PP, Smith D, Key J, Dong H, Ganapathysamy A, Maranda V, Wong NKY, Fernandez ML, Kim H, Zhang G, Ewanowich C, Hopkins L, Freywald A, Postovit LM, Köbel M, Fu Y, Vizeacoumar FS, Vizeacoumar FJ, Carey MS, Lee CH. Kumar PP, et al. Among authors: carey ms. Gynecol Oncol. 2024 Sep;188:162-168. doi: 10.1016/j.ygyno.2024.06.029. Epub 2024 Jul 5. Gynecol Oncol. 2024. PMID: 38970843 Free article.
High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma.
Hollis RL, Elliott R, Dawson JC, Ilenkovan N, Matthews RM, Stillie LJ, Oswald AJ, Kim H, Llaurado Fernandez M, Churchman M, Porter JM, Roxburgh P, Unciti-Broceta A, Gershenson DM, Herrington CS, Carey MS, Carragher NO, Gourley C. Hollis RL, et al. Among authors: carey ms. Gynecol Oncol. 2024 Jul;186:42-52. doi: 10.1016/j.ygyno.2024.03.029. Epub 2024 Apr 5. Gynecol Oncol. 2024. PMID: 38582027 Free article.
93 results